APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
Recruiting · NCT05119842 · Registry updated 2025-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study | Neurologic Manifestations, Paralysis, Unilateral, Vocal Cord, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vocal Cord Paralysis, cranial nerve neuropathy, laryngeal disorder, nervous system disorder, otorhinolaryngologic disease, palsy, respiratory system disorder, vagus nerve disorder | Recruiting | Not applicable | 2025-02-06 | NCT05119842 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| APrevent Biotech GmbH | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 21 |
| Greater Baltimore Medical Center | Baltimore | United States | 98 |
| Mayo Clinic - Phoenix | Phoenix | United States | 7 |
| Medical University of Vienna | Vienna | Austria | 35 |
| SRH Wald-Klinikum Gera | Gera | Germany | 2 |
| The University of Texas Health Science Center at Houston | Houston | United States | 207 |
| University Medical Center | Hamburg | Germany | 1 |